Test`Bank`For`Basic`Pharmacology`for`Nurses`18th`Edition`by`Michelle`Willihnganz,`Bruce
`D.`Clayton`Chapter`1-48
TABLE`OF`CONTENTS.
Unit`1:`Applying`Pharmacology`to`Nursing`Practice
Chapter`1:`Drug`Definitions,`Standards,`and`Information`Sources
`Chapter`2:`Basic`Principles`of`Drug`Action`and`Drug`Interaction
Chapter`3:`Drug`Action`Across`the`Life`Span
Chapter`4:`The`Nursing`Process`and`Pharmacology
`Chapter`5:`Patient`Education`to`Promote`Health
Unit`2:`Illustrated`Atlas`of`Medication`Administration
Chapter`6:`Principles`of`Medication`Administration`and`Medication`Safety`
Chapter`7:`Percutaneous`Administration
Chapter`8:`Enteral`Administration
Chapter`9:`Parenteral`Administration:`Safe`Preparation`of`Parenteral`Medications
`Chapter`10:`Parenteral`Administration:`Intradermal,`Subcutaneous,`and`Intramuscular`R
outes
Chapter`11:`Parenteral`Administration:`Intravenous`Route
Unit`3:`Drugs`Affecting`the`Autonomic`and`Central`Nervous`Systems
Chapter`12:`Drugs`Affecting`the`Autonomic`Nervous`System`
Chapter`13:`Drugs`Used`for`Sleep
Chapter`14:`Drugs`Used`for`Neurodegenerative`Disorders`(NEW!)`
Chapter`15:`Drugs`Used`for`Anxiety`Disorders
Chapter`16:`Drugs`Used`for`Depressive`and`Bipolar`Disorders`
Chapter`17:`Drugs`Used`for`Psychoses
Chapter`18:`Drugs`Used`for`Seizure`Disorders`
Chapter`19:`Drugs`Used`for`Pain`Management` Un
it`4:`Drugs`Affecting`the`Cardiovascular`System
Chapter`20:`Introduction`to`Cardiovascular`Disease`and`Metabolic`Syndrome`
Chapter`21:`Drugs`Used`to`Treat`Dyslipidemias
Chapter`22:`Drugs`Used`to`Treat`Hypertension`
Chapter`23:`Drugs`Used`to`Treat`Dysrhythmias`
Chapter`24:`Drugs`Used`to`Treat`Angina`Pectoris
Chapter`25:`Drugs`Used`to`Treat`Peripheral`Vascular`Disease
`Chapter`26:`Drugs`Used`to`Treat`Thromboembolic`Disorder
Chapter`27:`Drugs`Used`to`Treat`Heart`Failure
Chapter`28:`Drugs`Used`for`Diuresis
Unit`5:`Drugs`Affecting`the`Respiratory`System
Chapter`29:`Drugs`Used`to`Treat`Upper`Respiratory`Disease
`Chapter`30:`Drugs`Used`to`Treat`Lower`Respiratory`Diseas
e`Unit`6:`Drugs`Affecting`the`Digestive`System
Chapter`31:`Drugs`Used`to`Treat`Oral`Disorders
Chapter`32:`Drugs`Used`to`Treat`Gastroesophageal`Reflux`and`Peptic`Ulcer`Disease`
Chapter`33:`Drugs`Used`to`Treat`Nausea`and`Vomiting
Chapter`34:`Drugs`Used`to`Treat`Constipation`and`Diarrhea
Unit`7:`Drugs`That`Affect`the`Endocrine`System
`Chapter`35:`Drugs`Used`to`Treat`Diabetes`Mellitus`
Chapter`36:`Drugs`Used`to`Treat`Thyroid`Disease`
Chapter`37:`Corticosteroids
Chapter`38:`Gonadal`Hormones
Unit`8:`Drugs`Affecting`the`Reproductive`System
Chapter`39:`Drugs`Used`in`Obstetrics
Chapter`40:`Drugs`Used`in`Men‘s`and`Women‘s`Health
Unit`9:`Drugs`Affecting`Other`Body`Systems
Chapter`41:`Drugs`Used`to`Treat`Disorders`of`the`Urinary`System`
Chapter`42:`Drugs`Used`to`Treat`Glaucoma`and`Other`Eye`Disorders`
Chapter`43:`Drugs`Used`to`Treat`Cancer
Chapter`44:`Drugs`Used`to`Treat`the`Musculoskeletal`System
Chapter`45:`Drugs`Used`to`Treat`Infection`Unit`10:`Drugs`Affecting`the`General`Health`of`the`Body`
Chapter`46:`Nutrition
Chapter`47:`Herbal`and`Dietary`Supplemental`Therapy`
Chapter`48:`Substance`Abuse
,Chapter`01:`Drug`Definitions,`Standards,`and`Information`Sources`Willihng
anz:`Clayton’s`Basic`Pharmacology`for`Nurses,`18th`Edition
MULTIPLE`CHOICE
1. What`is`the`name`under`which`a`drug`is`listed`by`the`US`Food`and`Drug`
Administration`(FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:`C
The`official`name`is`the`name`under`which`a`drug`is`listed`by`the`FDA.`
The`brand`name,`or`trademark,`is`the`name`given`to`a`drug`by`its`manuf
acturer.`The`nonproprietary,`or`generic,`name`is`provided`by`the`United
`States`Adopted`Names`Council.
DIF: Cognitive`Level:`Knowledge REF:` p.`2
OBJ:`1`NAT:NCLEXClient`NeedsCategory:`Safe,`Effective`Care`
Environment`TOP:NursingProcess`Step:`Assessment
CON:` Patient`Education
2. Which`source`contains`information`specific`to`nutritional`supplements?
a. USP`Dictionary`of`USAN` &`International`Drug`Names
b. Natural`Medicines`Comprehensive`Database
c. United`States`Pharmacopoeia/National`Formulary`(USP`NF)
d. Drug`Interaction`Facts
ANS:`C
United`States`Pharmacopoeia/National`Formulary`contains`information`specific`to`nutritional`su
pplements.`USP`Dictionary`of`USAN`&`International`Drug`Names`is`a`compilation`of`drug`name
s,`pronunciation`guide,`and`possible`future`FDA`approved`drugs;`it`does`not`include`nutritional`s
upplements.`Natural`Medicines`Comprehensive`Database`contains`evidence-
based`information`on`herbal`medicines`and`herbal`combination`products;`it`does`not`include`infor
mation`specific`to`nutritional`supplements.`Drug`Interaction`Facts`contains`comprehensive`infor
mation`on`drug`interaction`facts;`it`does`not`include`nutritional`supplements.
DIF: Cognitive`Level:`Knowledge REF:` p.`2`|`p.`3
OBJ:`3`NAT:NCLEXClient`NeedsCategory:`Physiological`Integrity`TO
P:NursingProcess`Step:`Assessment CON:` Nutrition`|`Patient`Education
3. What`is`the`most`comprehensive`reference`available`to`research`a`drug`interaction?
a. Drug`Facts`and`Comparisons
b. Drug`Interaction`Facts
c. Handbook`on`Injectable`Drugs
d. Martindale—The`Complete`Drug`Reference
, ANS:`B
First`published`in`1983,`Drug`Interaction`Facts`is`the`most`comprehensive`book`available`on`dru
g`interactions.`In`addition`to`monographs`listing`various`aspects`of`drug`interactions,`this`informa
tion`is`reviewed`and`updated`by`an`internationally`renowned`group`of`physicians`and`pharmacists
`with`clinical`and`scientific`expertise.
DIF: Cognitive`Level:`Comprehension REF:` p.`4
OBJ:`3`NAT:NCLEXClient`NeedsCategory:`Physiological`Integri
ty
TOP:NursingProcess`Step:`Assessment CON:` Safety`|`Patient`Education`|`Clinical`Judgment
4. The`physician`has`written`an`order`for`a`drug`with`which`the`nurse`is`unfamiliar.`Which`section`
of`the`Physicians’`Desk`Reference`(PDR)`is`most`helpful`to`get`information`about`this`drug?
a. Manufacturer‘s`section
b. Brand`and`Generic`name`section
c. Product`category`section
d. Product`information`section
ANS:`B
A`physician‘s`order`would`include`the`brand`and/or`generic`name`of`the`drug.`The`alphabetic`ind
ex`in`the`PDR`would`make`this`section`the`most`user-
friendly.`Based`on`a`physician‘s`order,`manufacturer‘s`information`and`classification`information
`would`not`be`known.`The`Manufacturer‘s`section`is`a`roster`of`manufacturers.`The`product`categ
ory`section`lists`products`subdivided`by`therapeutic`classes,`such`as`analgesics,`laxatives,`oxytoci
cs,`and`antibiotics.`The`product`information`section`contains`reprints`of`the`package`inserts`for`th
e`major`products`of`manufacturers.
DIF: Cognitive`Level:`Comprehension REF:` p.`4
OBJ:`3`NAT:NCLEXClient`NeedsCategory:`Physiological`Integri
ty
TOP:NursingProcess`Step:`Planning CON:` Safety`|`Patient`Education`|`Clinical`Judgment
5. Which`online`drug`reference`makes`available`to`healthcare`providers`and`the`public`a`standard,`
comprehensive,`up-to-date`look`up`and`downloadable`resource`about`medicines?
a. American`Drug`Index
b. American`Hospital`Formulary
c. DailyMed
d. Physicians’`Desk`Reference`(PDR)
ANS:`C
DailyMed`makes`available`to`healthcare`providers`and`the`public`a`standard,`comprehensive,`up-
`to-
date`look`up`and`downloadable`resource`about`medicines.`The`American`Drug`Index`is`not`appro
priate`for`patient`use.`The`American`Hospital`Formulary`is`not`appropriate`for`patient`use.`The`P
DR`is`not`appropriate`for`patient`use.
DIF: Cognitive`Level:`Knowledge REF:` p.`3`|`p.`5
OBJ:`4`NAT:NCLEXClient`NeedsCategory:`Physiological`Integri
ty`TOP:NursingProcess`Step:`Implementation
CON:` Safety`|`Patient`Education`|`Clinical`Judgment
6. Which`legislation`authorizes`the`FDA`to`determine`the`safety`of`a`drug`before`its`marketing?
, a. Federal`Food,`Drug,`and`Cosmetic`Act`(1938)
b. Durham`Humphrey`Amendment`(1952)
c. Controlled`Substances`Act`(1970)
d. Kefauver`Harris`Drug`Amendment`(1962)
ANS:`A
The`Federal`Food,`Drug,`and`Cosmetic`Act`of`1938`authorized`the`FDA`to`determine`the`safety`of
`all`drugs`before`marketing.`Later`amendments`and`acts`helped`tighten`FDA`control`and`ensure`dru
g`safety.`The`Durham`Humphrey`Amendment`defines`the`kinds`of`drugs`that`cannot`be`used`safel
y`without`medical`supervision`and`restricts`their`sale`to`prescription`by`a`licensed`practitioner.`Th
e`Controlled`Substances`Act`addresses`only`controlled`substances`and`their`categorization.`The`K
efauver`Harris`Drug`Amendment`ensures`drug`efficacy`and`greater`drug`safety.`Drug`manufactur
ers`are`required`to`prove`to`the`FDA`the`effectiveness`of`their`products`before`marketing`them.
DIF: Cognitive`Level:`Knowledge REF:` p.`5
OBJ:`6`NAT:NCLEXClient`NeedsCategory:`Physiological`Integri
ty`TOP:NursingProcess`Step:`Assessment
CON:` Safety`|`Patient`Education`|`Evidence`|`Health`Care`Law
7. Meperidine`(Demerol)`is`a`narcotic`with`a`high`potential`for`physical`and`psychological`
dependency.`Under`which`classification`does`this`drug`fall?
a. I
b. II
c. III
d. IV
ANS:`B
Meperidine`(Demerol)`is`a`Schedule`II`drug;`it`has`a`high`potential`for`abuse`and`may`lead`to`sev
ere`psychological`and`physical`dependence.`Schedule`I`drugs`have`high`potential`for`abuse`and`n
o`recognized`medical`use.`Schedule`III`drugs`have`some`potential`for`abuse.`Use`may`lead`to`low`t
o`moderate`physical`dependence`or`high`psychological`dependence.`Schedule`IV`drugs`have`low`
potential`for`abuse.`Use`may`lead`to`limited`physical`or`psychological`dependence.
DIF: Cognitive`Level:`Comprehension REF:` p.`5
OBJ:`2`NAT:NCLEXClient`NeedsCategory:`Safe,`Effective`Care`Environment`
TOP:NursingProcess`Step:`Assessment CON:` Patient`Education`|`Addiction`|`Pain
8. What`would`the`FDA`do`to`expedite`drug`development`and`approval`for`an`outbreak`of`s
mallpox,`for`which`there`is`no`known`treatment?
a. List`smallpox`as`a`health`orphan`disease.
b. Omit`the`preclinical`research`phase.
c. Extend`the`clinical`research`phase.
d. Fast`track`the`investigational`drug.
ANS:`D
`D.`Clayton`Chapter`1-48
TABLE`OF`CONTENTS.
Unit`1:`Applying`Pharmacology`to`Nursing`Practice
Chapter`1:`Drug`Definitions,`Standards,`and`Information`Sources
`Chapter`2:`Basic`Principles`of`Drug`Action`and`Drug`Interaction
Chapter`3:`Drug`Action`Across`the`Life`Span
Chapter`4:`The`Nursing`Process`and`Pharmacology
`Chapter`5:`Patient`Education`to`Promote`Health
Unit`2:`Illustrated`Atlas`of`Medication`Administration
Chapter`6:`Principles`of`Medication`Administration`and`Medication`Safety`
Chapter`7:`Percutaneous`Administration
Chapter`8:`Enteral`Administration
Chapter`9:`Parenteral`Administration:`Safe`Preparation`of`Parenteral`Medications
`Chapter`10:`Parenteral`Administration:`Intradermal,`Subcutaneous,`and`Intramuscular`R
outes
Chapter`11:`Parenteral`Administration:`Intravenous`Route
Unit`3:`Drugs`Affecting`the`Autonomic`and`Central`Nervous`Systems
Chapter`12:`Drugs`Affecting`the`Autonomic`Nervous`System`
Chapter`13:`Drugs`Used`for`Sleep
Chapter`14:`Drugs`Used`for`Neurodegenerative`Disorders`(NEW!)`
Chapter`15:`Drugs`Used`for`Anxiety`Disorders
Chapter`16:`Drugs`Used`for`Depressive`and`Bipolar`Disorders`
Chapter`17:`Drugs`Used`for`Psychoses
Chapter`18:`Drugs`Used`for`Seizure`Disorders`
Chapter`19:`Drugs`Used`for`Pain`Management` Un
it`4:`Drugs`Affecting`the`Cardiovascular`System
Chapter`20:`Introduction`to`Cardiovascular`Disease`and`Metabolic`Syndrome`
Chapter`21:`Drugs`Used`to`Treat`Dyslipidemias
Chapter`22:`Drugs`Used`to`Treat`Hypertension`
Chapter`23:`Drugs`Used`to`Treat`Dysrhythmias`
Chapter`24:`Drugs`Used`to`Treat`Angina`Pectoris
Chapter`25:`Drugs`Used`to`Treat`Peripheral`Vascular`Disease
`Chapter`26:`Drugs`Used`to`Treat`Thromboembolic`Disorder
Chapter`27:`Drugs`Used`to`Treat`Heart`Failure
Chapter`28:`Drugs`Used`for`Diuresis
Unit`5:`Drugs`Affecting`the`Respiratory`System
Chapter`29:`Drugs`Used`to`Treat`Upper`Respiratory`Disease
`Chapter`30:`Drugs`Used`to`Treat`Lower`Respiratory`Diseas
e`Unit`6:`Drugs`Affecting`the`Digestive`System
Chapter`31:`Drugs`Used`to`Treat`Oral`Disorders
Chapter`32:`Drugs`Used`to`Treat`Gastroesophageal`Reflux`and`Peptic`Ulcer`Disease`
Chapter`33:`Drugs`Used`to`Treat`Nausea`and`Vomiting
Chapter`34:`Drugs`Used`to`Treat`Constipation`and`Diarrhea
Unit`7:`Drugs`That`Affect`the`Endocrine`System
`Chapter`35:`Drugs`Used`to`Treat`Diabetes`Mellitus`
Chapter`36:`Drugs`Used`to`Treat`Thyroid`Disease`
Chapter`37:`Corticosteroids
Chapter`38:`Gonadal`Hormones
Unit`8:`Drugs`Affecting`the`Reproductive`System
Chapter`39:`Drugs`Used`in`Obstetrics
Chapter`40:`Drugs`Used`in`Men‘s`and`Women‘s`Health
Unit`9:`Drugs`Affecting`Other`Body`Systems
Chapter`41:`Drugs`Used`to`Treat`Disorders`of`the`Urinary`System`
Chapter`42:`Drugs`Used`to`Treat`Glaucoma`and`Other`Eye`Disorders`
Chapter`43:`Drugs`Used`to`Treat`Cancer
Chapter`44:`Drugs`Used`to`Treat`the`Musculoskeletal`System
Chapter`45:`Drugs`Used`to`Treat`Infection`Unit`10:`Drugs`Affecting`the`General`Health`of`the`Body`
Chapter`46:`Nutrition
Chapter`47:`Herbal`and`Dietary`Supplemental`Therapy`
Chapter`48:`Substance`Abuse
,Chapter`01:`Drug`Definitions,`Standards,`and`Information`Sources`Willihng
anz:`Clayton’s`Basic`Pharmacology`for`Nurses,`18th`Edition
MULTIPLE`CHOICE
1. What`is`the`name`under`which`a`drug`is`listed`by`the`US`Food`and`Drug`
Administration`(FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:`C
The`official`name`is`the`name`under`which`a`drug`is`listed`by`the`FDA.`
The`brand`name,`or`trademark,`is`the`name`given`to`a`drug`by`its`manuf
acturer.`The`nonproprietary,`or`generic,`name`is`provided`by`the`United
`States`Adopted`Names`Council.
DIF: Cognitive`Level:`Knowledge REF:` p.`2
OBJ:`1`NAT:NCLEXClient`NeedsCategory:`Safe,`Effective`Care`
Environment`TOP:NursingProcess`Step:`Assessment
CON:` Patient`Education
2. Which`source`contains`information`specific`to`nutritional`supplements?
a. USP`Dictionary`of`USAN` &`International`Drug`Names
b. Natural`Medicines`Comprehensive`Database
c. United`States`Pharmacopoeia/National`Formulary`(USP`NF)
d. Drug`Interaction`Facts
ANS:`C
United`States`Pharmacopoeia/National`Formulary`contains`information`specific`to`nutritional`su
pplements.`USP`Dictionary`of`USAN`&`International`Drug`Names`is`a`compilation`of`drug`name
s,`pronunciation`guide,`and`possible`future`FDA`approved`drugs;`it`does`not`include`nutritional`s
upplements.`Natural`Medicines`Comprehensive`Database`contains`evidence-
based`information`on`herbal`medicines`and`herbal`combination`products;`it`does`not`include`infor
mation`specific`to`nutritional`supplements.`Drug`Interaction`Facts`contains`comprehensive`infor
mation`on`drug`interaction`facts;`it`does`not`include`nutritional`supplements.
DIF: Cognitive`Level:`Knowledge REF:` p.`2`|`p.`3
OBJ:`3`NAT:NCLEXClient`NeedsCategory:`Physiological`Integrity`TO
P:NursingProcess`Step:`Assessment CON:` Nutrition`|`Patient`Education
3. What`is`the`most`comprehensive`reference`available`to`research`a`drug`interaction?
a. Drug`Facts`and`Comparisons
b. Drug`Interaction`Facts
c. Handbook`on`Injectable`Drugs
d. Martindale—The`Complete`Drug`Reference
, ANS:`B
First`published`in`1983,`Drug`Interaction`Facts`is`the`most`comprehensive`book`available`on`dru
g`interactions.`In`addition`to`monographs`listing`various`aspects`of`drug`interactions,`this`informa
tion`is`reviewed`and`updated`by`an`internationally`renowned`group`of`physicians`and`pharmacists
`with`clinical`and`scientific`expertise.
DIF: Cognitive`Level:`Comprehension REF:` p.`4
OBJ:`3`NAT:NCLEXClient`NeedsCategory:`Physiological`Integri
ty
TOP:NursingProcess`Step:`Assessment CON:` Safety`|`Patient`Education`|`Clinical`Judgment
4. The`physician`has`written`an`order`for`a`drug`with`which`the`nurse`is`unfamiliar.`Which`section`
of`the`Physicians’`Desk`Reference`(PDR)`is`most`helpful`to`get`information`about`this`drug?
a. Manufacturer‘s`section
b. Brand`and`Generic`name`section
c. Product`category`section
d. Product`information`section
ANS:`B
A`physician‘s`order`would`include`the`brand`and/or`generic`name`of`the`drug.`The`alphabetic`ind
ex`in`the`PDR`would`make`this`section`the`most`user-
friendly.`Based`on`a`physician‘s`order,`manufacturer‘s`information`and`classification`information
`would`not`be`known.`The`Manufacturer‘s`section`is`a`roster`of`manufacturers.`The`product`categ
ory`section`lists`products`subdivided`by`therapeutic`classes,`such`as`analgesics,`laxatives,`oxytoci
cs,`and`antibiotics.`The`product`information`section`contains`reprints`of`the`package`inserts`for`th
e`major`products`of`manufacturers.
DIF: Cognitive`Level:`Comprehension REF:` p.`4
OBJ:`3`NAT:NCLEXClient`NeedsCategory:`Physiological`Integri
ty
TOP:NursingProcess`Step:`Planning CON:` Safety`|`Patient`Education`|`Clinical`Judgment
5. Which`online`drug`reference`makes`available`to`healthcare`providers`and`the`public`a`standard,`
comprehensive,`up-to-date`look`up`and`downloadable`resource`about`medicines?
a. American`Drug`Index
b. American`Hospital`Formulary
c. DailyMed
d. Physicians’`Desk`Reference`(PDR)
ANS:`C
DailyMed`makes`available`to`healthcare`providers`and`the`public`a`standard,`comprehensive,`up-
`to-
date`look`up`and`downloadable`resource`about`medicines.`The`American`Drug`Index`is`not`appro
priate`for`patient`use.`The`American`Hospital`Formulary`is`not`appropriate`for`patient`use.`The`P
DR`is`not`appropriate`for`patient`use.
DIF: Cognitive`Level:`Knowledge REF:` p.`3`|`p.`5
OBJ:`4`NAT:NCLEXClient`NeedsCategory:`Physiological`Integri
ty`TOP:NursingProcess`Step:`Implementation
CON:` Safety`|`Patient`Education`|`Clinical`Judgment
6. Which`legislation`authorizes`the`FDA`to`determine`the`safety`of`a`drug`before`its`marketing?
, a. Federal`Food,`Drug,`and`Cosmetic`Act`(1938)
b. Durham`Humphrey`Amendment`(1952)
c. Controlled`Substances`Act`(1970)
d. Kefauver`Harris`Drug`Amendment`(1962)
ANS:`A
The`Federal`Food,`Drug,`and`Cosmetic`Act`of`1938`authorized`the`FDA`to`determine`the`safety`of
`all`drugs`before`marketing.`Later`amendments`and`acts`helped`tighten`FDA`control`and`ensure`dru
g`safety.`The`Durham`Humphrey`Amendment`defines`the`kinds`of`drugs`that`cannot`be`used`safel
y`without`medical`supervision`and`restricts`their`sale`to`prescription`by`a`licensed`practitioner.`Th
e`Controlled`Substances`Act`addresses`only`controlled`substances`and`their`categorization.`The`K
efauver`Harris`Drug`Amendment`ensures`drug`efficacy`and`greater`drug`safety.`Drug`manufactur
ers`are`required`to`prove`to`the`FDA`the`effectiveness`of`their`products`before`marketing`them.
DIF: Cognitive`Level:`Knowledge REF:` p.`5
OBJ:`6`NAT:NCLEXClient`NeedsCategory:`Physiological`Integri
ty`TOP:NursingProcess`Step:`Assessment
CON:` Safety`|`Patient`Education`|`Evidence`|`Health`Care`Law
7. Meperidine`(Demerol)`is`a`narcotic`with`a`high`potential`for`physical`and`psychological`
dependency.`Under`which`classification`does`this`drug`fall?
a. I
b. II
c. III
d. IV
ANS:`B
Meperidine`(Demerol)`is`a`Schedule`II`drug;`it`has`a`high`potential`for`abuse`and`may`lead`to`sev
ere`psychological`and`physical`dependence.`Schedule`I`drugs`have`high`potential`for`abuse`and`n
o`recognized`medical`use.`Schedule`III`drugs`have`some`potential`for`abuse.`Use`may`lead`to`low`t
o`moderate`physical`dependence`or`high`psychological`dependence.`Schedule`IV`drugs`have`low`
potential`for`abuse.`Use`may`lead`to`limited`physical`or`psychological`dependence.
DIF: Cognitive`Level:`Comprehension REF:` p.`5
OBJ:`2`NAT:NCLEXClient`NeedsCategory:`Safe,`Effective`Care`Environment`
TOP:NursingProcess`Step:`Assessment CON:` Patient`Education`|`Addiction`|`Pain
8. What`would`the`FDA`do`to`expedite`drug`development`and`approval`for`an`outbreak`of`s
mallpox,`for`which`there`is`no`known`treatment?
a. List`smallpox`as`a`health`orphan`disease.
b. Omit`the`preclinical`research`phase.
c. Extend`the`clinical`research`phase.
d. Fast`track`the`investigational`drug.
ANS:`D
